TAAV Biomanufacturing Solutions
Enzymatic DNA Manufacturing
Enzymatic DNA Manufacturing
neDNA™: Enzymatic DNA for rAAV Manufacturing
We are a CDMO working with biopharma companies, research centers and entities developing programs based on rAAV-based gene therapies.
neDNA™: Discover TAAV manufactured enzymatic DNA

An alternative to plasmids for rAAV manufacturing
We provide the first option for critical starting material for rAAV manufacturing. Designed to transform and accelerate the traditional gene therapy development timelines.
TAAV’s enzymatic DNA is a synthetic, linear, double-stranded, closed-ended molecule which we aim to be the new standard for transfection-based AAV generation.
Our goal
As individuals,
we dream
about future.
As scientists, we have
the chance to make
history.
Together, we have the
power to make it
happen.
Your rAAV manufacturing starts now! We work in a uniquely collaborative industry that can make the world a better place. Let’s make it happen together.
Your rAAV manufacturing starts now. We work in a uniquely collaborative industry that can make the world a better place. Let’s make it happen together.
Led by Science. Inspired by People.
We are a highly innovative
company.
Our solution opens the door to a new area for gene therapy development. This innovation can be only understood by the power of science. But science needs hands. Science needs people committed to the future and passionate to change for better outcomes. We are aimed at changing patients’ lives: this is what inspire us.
We are an innovative life sciences company with the unique purpose of improving people’s lives. This is what inspire us.
Latest news:

ESGCT 2023
We are proud of being a Silver Sponsor of the ESGCT 2023, the European Society of

Meeting on the MESA 2023
We are Silver Sponsor of the Alliance for Regenerative Medicine’s 2023 Cell and Gene Meeting on
Poster: Advanced Characterization of neDNA™ Final Product by HPLC
Download here the poster.

12th SETGYC Biennial Congress
Meet us at the SETGYC 12th Biennial Congress. The Spanish Association of Gene and Cell Therapies